Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9388189

    Pyrrolotriazinone derivatives as PI3K inhibitors

    Almirall, S.A. · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9388221

    Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9388218

    PRRSV compositions

    Regents of the University of Minnesota · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9388164

    Methods of using pyruvate kinase activators

    Agios Pharmaceuticals, Inc. · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9388104

    Chemically modified small molecules

    Nektar Therapeutics · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9394269

    Process-scale synthesis of urolithins

    Amazentis SA · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9394369

    Luminescent porous silicon nanoparticles for targeted delivery and immunization

    The Regents of the University of California · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9394541

    Oral delivery of nucleic acid-based gene interfering agents by Salmonella

    The Regents of the University of California · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9394569

    Methods and kits for early detection of cancer or predisposition thereto

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9393285

    Compositions for treating dry eye disease

    The Regents of the University of California · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9395369

    Guinea pig cytomegalovirus (CIDMTR strain)

    Regents of the University of Minnesota · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9394545

    Methods and compositions for regulation of transgene expression

    Sangamo Biosciences, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9393235

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9394343

    Appetite stimulating protein

    The Regents of the University of California · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9393257

    TALEN-based gene correction

    Regents of the University of Minnesota · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9394540

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9394359

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9394323

    Antisense antiviral compound and method for treating influenza viral infection

    Sarepta Therapeutics, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9394302

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9394275

    Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

    Theravance Respiratory Company, LLC · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9393351

    Cloned biological material medical device and method thereof

    FIRST PRINCIPLES, INC. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9393245

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9393305

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9394234

    Lipid formulations

    ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9394338

    Glutathione analogs and uses thereof

    Regents of the University of Minnesota · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9394316

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9394303

    Small molecule inhibitors of MCL-1 and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9394329

    Glucopyranosyl derivatives and their uses in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9394352

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9393203

    Osmotic drug delivery system

    Supernus Pharmaceuticals, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9393306

    Singlet oxygen-labile linkers and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9393271

    GHRH agonists for islet cell transplantation and function and the treatment of diabetes

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9394241

    Composition and method for making oligo-benzamide compounds

    The Board of Regents of the University of Texas System · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9394281

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9394358

    Gene signature for predicting prognosis of patients with solid tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9394531

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Biosciences, Inc. · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9394364

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. EP 3044215

    VERFAHREN ZUR HERSTELLUNG VON MEDIKAMENTEN ZUR BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN UND DARIN VERWENDETE ZWISCHENPRODUKTE

    BIAL PORTELA & CA SA [PT] · Granted Wed Jul 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 2016206702

    PEGylated Recombinant Human Growth Hormone Compounds

    ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS [DK] · Granted Thu Jul 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. CA 2970060

    COMBINAISON DE BENZYDAMINE ET D'UN ANTIFONGIQUE POUR LE TRAITEMENT DE LA MYCOSE

    ACRAF [IT] · Granted Thu Jul 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9399672

    Hepatitis C virus neutralizing antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9399639

    Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9399033

    Oligomer-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9399666

    Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9399070

    Compositions comprising a polymeric reagent and a pharmacologically active agent

    Nektar Therapeutics · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9399627

    Substituted macrocyclic compounds having proteasome inhibitory activity

    The Regents of the University of California · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9399637

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9399649

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.